177Lu-DTPA-SC16.56

· Memorial Sloan Kettering Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-DTPA-SC16.56, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate [Phase 1]